| Schedule of financial information by reportable segment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended June 30, |
|
|
2023 |
|
2022 |
|
2021 |
Net sales: |
|
|
|
|
|
|
|
|
|
Protein Sciences |
|
$ |
845,747 |
|
$ |
832,311 |
|
$ |
704,564 |
Diagnostics and Genomics |
|
|
292,602 |
|
|
274,843 |
|
|
227,744 |
Intersegment |
|
|
(1,647) |
|
|
(1,555) |
|
|
(1,276) |
Consolidated net sales |
|
$ |
1,136,702 |
|
$ |
1,105,599 |
|
$ |
931,032 |
|
|
|
|
|
|
|
|
|
|
Operating income: |
|
|
|
|
|
|
|
|
|
Protein Sciences |
|
$ |
373,684 |
|
$ |
377,623 |
|
$ |
330,225 |
Diagnostics and Genomics |
|
|
43,037 |
|
|
48,977 |
|
|
38,425 |
Segment operating income |
|
|
416,721 |
|
|
426,600 |
|
|
368,650 |
Costs recognized on sale of acquired inventory |
|
|
(400) |
|
|
(1,596) |
|
|
(1,565) |
Amortization of intangibles |
|
|
(76,413) |
|
|
(73,054) |
|
|
(64,239) |
Impact of partially-owned consolidated subsidiaries(1) |
|
|
647 |
|
|
(2,393) |
|
|
(1,505) |
Acquisition related expenses and other |
|
|
9,965 |
|
|
19,070 |
|
|
(7,114) |
Eminence impairment |
|
|
— |
|
|
(18,715) |
|
|
— |
Stock based compensation, inclusive of employer taxes |
|
|
(41,217) |
|
|
(46,401) |
|
|
(51,846) |
Restructuring costs |
|
|
(3,829) |
|
|
(1,640) |
|
|
(142) |
Corporate general, selling, and administrative expenses |
|
|
(6,530) |
|
|
(5,281) |
|
|
(4,943) |
Consolidated operating income |
|
$ |
298,944 |
|
$ |
296,590 |
|
$ |
237,296 |
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended June 30, |
|
|
2023 |
|
2022 |
|
2021 |
Consumables revenue - Protein Sciences |
|
$ |
665,301 |
|
$ |
646,952 |
|
$ |
557,037 |
Consumables revenue - Diagnostics and Genomics |
|
|
252,432 |
|
|
243,922 |
|
|
194,948 |
Total consumable revenue |
|
$ |
917,733 |
|
$ |
890,874 |
|
$ |
751,985 |
|
|
|
|
|
|
|
|
|
Year ended June 30, |
|
|
2023 |
|
2022 |
Long-lived assets: |
|
|
|
|
|
|
United States and Canada |
|
$ |
203,657 |
|
$ |
203,732 |
Europe |
|
|
19,263 |
|
|
16,223 |
Asia |
|
|
3,280 |
|
|
3,287 |
Total long-lived assets |
|
$ |
226,200 |
|
$ |
223,242 |
Intangible assets: |
|
|
|
|
|
|
United States and Canada |
|
$ |
529,652 |
|
$ |
523,536 |
Europe |
|
|
4,553 |
|
|
6,281 |
Asia |
|
|
440 |
|
|
1,705 |
Total intangible assets |
|
$ |
534,645 |
|
$ |
531,522 |
|